Key Events This Week
5 Jan: Stock hits 52-week low at Rs.23.75
6 Jan: New all-time low recorded at Rs.23.71
7 Jan: Further decline to Rs.23.59, marking continued downtrend
8 Jan: Stock falls to Rs.23.20, hitting fresh 52-week and all-time low
9 Jan: Week closes at Rs.22.66, down 2.83% on the day
5 January 2026: Stock Hits 52-Week Low at Rs.23.75
Mukka Proteins Ltd opened the week under pressure, closing at Rs.23.75, marking a fresh 52-week low. The stock declined 1.04% on the day, underperforming the Sensex which fell 0.18%. This decline came despite the broader market showing resilience, with the Sensex trading near its 52-week high. The stock’s price fell below all key moving averages, signalling sustained bearish momentum. Financially, the company faces challenges with a modest Return on Capital Employed (ROCE) of 9.16% and a high Debt to EBITDA ratio of 5.26 times, reflecting elevated leverage and constrained profitability.
6 January 2026: All-Time Low at Rs.23.71 Amid Continued Downtrend
The downward trajectory continued on 6 January, with the stock touching a new all-time low of Rs.23.71, down 0.34% from the previous close. This marked the third consecutive day of decline, with the stock underperforming both the Sensex and its FMCG sector peers. The company’s quarterly earnings revealed a sharp 67.9% drop in Profit Before Tax excluding other income to Rs.3.28 crores, and a 45.9% decline in Profit After Tax to Rs.5.88 crores. Interest expenses peaked at Rs.12.82 crores, further pressuring profitability. Institutional investors reduced their holdings by 0.6%, now holding 3.36% of equity, reflecting cautious sentiment.
7 January 2026: Further Decline to Rs.23.59 Amid Persistent Financial Pressures
On 7 January, Mukka Proteins Ltd’s share price declined further to Rs.23.59, marking another 52-week and all-time low. The stock recorded a marginal gain intraday but closed down 0.38%, continuing a four-day losing streak. Despite a slight uptick, the stock remained below all major moving averages. The company’s financial metrics remained subdued, with net sales growth averaging 8.60% annually over five years, insufficient to offset rising costs and debt servicing. The stock’s Mojo Score stood at 37.0 with a Sell grade, downgraded from Strong Sell in November 2025.
Transformation in full progress! This Micro Cap from Auto Ancillary just achieved sustainable profitability after tough times. Be early to witness this powerful comeback story!
- - Sustainable profitability reached
- - Post-turnaround strength
- - Comeback story unfolding
8 January 2026: Stock Hits Rs.23.20, New 52-Week and All-Time Low
The downtrend intensified on 8 January as Mukka Proteins Ltd’s share price fell to Rs.23.20, a fresh 52-week and all-time low, down 1.40% on the day. The stock marginally outperformed its aquaculture sector peers, which declined 2.18%. Technical indicators remained bearish, with the stock trading below all key moving averages. Despite operating profit growth of 50.86% annually, the company’s net profits declined by 34% over the past year, highlighting ongoing margin pressures. Institutional investors continued to reduce their stake, reflecting cautious market sentiment.
Technical Momentum and Market Sentiment
Technical indicators signalled a shift from mildly bearish to bearish momentum. Daily moving averages remained bearish, and Bollinger Bands suggested sustained selling pressure. While weekly MACD and KST indicators showed mild bullish hints, these were insufficient to offset the dominant downtrend. The Relative Strength Index (RSI) on a monthly basis suggested potential oversold conditions, but volume trends as indicated by On-Balance Volume (OBV) were mildly bearish. Dow Theory assessments confirmed the bearish trend on both weekly and monthly timeframes. The stock’s Mojo Score of 31.0 and Sell grade reflect this cautious outlook.
9 January 2026: Week Closes at Rs.22.66, Marking 2.83% Daily Decline
The week concluded with Mukka Proteins Ltd’s share price falling to Rs.22.66, down 2.83% on 9 January, marking the sixth consecutive day of decline. The stock underperformed the Sensex, which fell 0.89% on the day. The share price reached a new all-time low, reflecting persistent financial and operational challenges. Profitability metrics remained subdued, with a ROCE of 9.16% and a high Debt to EBITDA ratio of 5.26 times. Quarterly earnings showed a 67.9% decline in Profit Before Tax excluding other income and a 45.9% drop in Profit After Tax. Institutional investors further reduced their holdings, now at 3.36%.
Holding Mukka Proteins Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Daily Price Comparison: Mukka Proteins Ltd vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-01-05 | Rs.23.82 | -1.04% | 37,730.95 | -0.18% |
| 2026-01-06 | Rs.23.74 | -0.34% | 37,657.70 | -0.19% |
| 2026-01-07 | Rs.23.65 | -0.38% | 37,669.63 | +0.03% |
| 2026-01-08 | Rs.23.32 | -1.40% | 37,137.33 | -1.41% |
| 2026-01-09 | Rs.22.66 | -2.83% | 36,807.62 | -0.89% |
Key Takeaways
Persistent Downtrend: Mukka Proteins Ltd’s stock has declined steadily over six consecutive trading days, hitting multiple 52-week and all-time lows, reflecting sustained bearish momentum.
Financial Strains: The company’s modest ROCE of 9.16% and high Debt to EBITDA ratio of 5.26 times highlight ongoing profitability and leverage challenges, exacerbated by rising interest expenses.
Declining Earnings: Quarterly Profit Before Tax excluding other income fell sharply by 67.9%, while Profit After Tax declined 45.9%, underscoring deteriorating profitability.
Institutional Sentiment: Institutional investors have reduced their holdings by 0.6% to 3.36%, signalling cautious sentiment amid financial and operational headwinds.
Valuation and Growth: Despite the downtrend, operating profit growth remains robust at 50.86% annually, and valuation metrics such as an Enterprise Value to Capital Employed ratio of 1.3 suggest the stock trades at a discount relative to peers.
Technical Indicators: Technical analysis confirms a bearish trend with the stock trading below all major moving averages and bearish signals from Bollinger Bands and Dow Theory, despite mild bullish hints from some oscillators.
Conclusion
Mukka Proteins Ltd’s share price decline of 5.86% over the week ending 9 January 2026 reflects a confluence of financial challenges, including subdued profitability, high leverage, and declining institutional interest. The stock’s persistent underperformance relative to the Sensex and sector peers highlights the severity of its current difficulties. While operating profit growth and valuation discounts offer some positive context, these have yet to translate into improved earnings or market sentiment. Technical indicators reinforce the bearish outlook, suggesting that the stock remains under pressure in the near term. Investors should monitor key financial metrics and technical signals closely as the company navigates this challenging phase.
Unlock special upgrade rates for a limited period. Start Saving Now →
